Log in to save to my catalogue

Home Use of an Artificial Beta Cell in Type 1 Diabetes

Home Use of an Artificial Beta Cell in Type 1 Diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4697362

Home Use of an Artificial Beta Cell in Type 1 Diabetes

About this item

Full title

Home Use of an Artificial Beta Cell in Type 1 Diabetes

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2015-11, Vol.373 (22), p.2129-2140

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In two randomized trials conducted under home conditions, investigators compared closed-loop insulin delivery with sensor-augmented pump therapy in adults and in children and adolescents for 12 weeks. The closed-loop approach improved glucose control and reduced hypoglycemia.
Intensive insulin therapy is the standard of care for type 1 diabetes...

Alternative Titles

Full title

Home Use of an Artificial Beta Cell in Type 1 Diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4697362

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4697362

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1509351

How to access this item